Media coverage
2
Media coverage
Title Casirivimab + Imdevimab Prevents Progression to Symptomatic COVID-19 Media name/outlet The Breeze: James Madison University Country/Territory United States Date 26/01/22 Persons Meagan P. O'Brien Title Casirivimab + Imdevimab Prevents Progression to Symptomatic COVID-19 Media name/outlet The Griffon News: Missouri Western State College Country/Territory United States Date 26/01/22 Persons Meagan P. O'Brien